ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals Ownership Summary
ACADIA Pharmaceuticals is owned by 97.79% institutional investors, 0.33% insiders, and 1.88% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.17% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.48% of its assets in ACADIA Pharmaceuticals shares.
ACAD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ACADIA Pharmaceuticals | 97.79% | 0.33% | 1.88% |
| Sector | Healthcare Stocks | 50.50% | 12.33% | 37.17% |
| Industry | Biotech Stocks | 49.09% | 12.06% | 38.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.91M | 25.17% | $1.09B |
| Blackrock funding, inc. /de | 22.52M | 13.20% | $569.63M |
| Vanguard group | 15.15M | 8.98% | $404.76M |
| Blackrock | 12.06M | 7.32% | $196.01M |
| State street | 9.08M | 5.32% | $229.63M |
| Rtw investments, lp | 7.14M | 4.19% | $180.76M |
| Vanguard capital management | 5.76M | 3.38% | $145.82M |
| Dimensional fund advisors lp | 3.69M | 2.17% | $93.48M |
| Geode capital management | 3.36M | 1.97% | $84.98M |
| Goldman sachs group | 2.58M | 1.51% | $65.28M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.91M | 5.44% | $1.09B |
| Birchview capital, lp | 171.00K | 2.02% | $4.33M |
| Verdad advisers, lp | 82.63K | 2.00% | $2.09M |
| Nan fung group | 102.98K | 1.98% | $2.61M |
| Rtw investments, lp | 7.14M | 1.54% | $180.76M |
| Braidwell lp | 1.65M | 1.54% | $41.65M |
| Sphera funds management | 356.53K | 1.18% | $9.02M |
| Frazier life sciences management | 1.44M | 0.79% | $36.39M |
| Rice hall james & associates | 618.89K | 0.76% | $15.66M |
| Tfg asset management gp | 167.88K | 0.67% | $4.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 1.76M | 0.04% | 1.69M |
| Norges bank | 1.62M | 0.00% | 1.62M |
| Citadel advisors | 2.18M | 0.01% | 1.56M |
| Qube research | 2.45M | 0.06% | 1.50M |
| Sixth street partners management company | 1.21M | 0.00% | 1.21M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| First trust advisors lp | 184.39K | 0.00% | -3.16M |
| Palo alto investors lp | - | - | -2.87M |
| Ecor1 capital | - | - | -1.35M |
| Finepoint capital lp | - | - | -905.38K |
| Braidwell lp | 1.65M | 1.54% | -824.80K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.62M | 0.00% | 1.62M | $41.07M |
| Sixth street partners management company | 1.21M | 0.00% | 1.21M | $30.52M |
| Alyeska investment group | 310.29K | 0.02% | 310.29K | $7.85M |
| Schonfeld strategic advisors | 284.16K | 0.03% | 284.16K | $7.19M |
| Hrt financial lp | 209.93K | 0.01% | 209.93K | $5.31M |
Sold Out
| Holder | Change |
|---|---|
| Curio wealth | -1.00 |
| Dunhill financial | -2.00 |
| Coppell advisory solutions | -4.00 |
| Wealthcollab | -5.00 |
| Abound wealth management | -7.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 359 | 0.56% | 166,753,651 | 1.22% | 97 | 1.03% | 182 | 13.75% | 108 | -16.92% |
| Mar 31, 2026 | 285 | -18.10% | 93,214,952 | -43.97% | 55 | 0.57% | 127 | -25.73% | 102 | -15.70% |
| Dec 31, 2025 | 107 | -69.69% | 24,070,676 | -85.64% | 14 | 0.14% | 52 | -72.92% | 38 | -64.15% |
| Sep 30, 2025 | 134 | -59.02% | 29,202,139 | -82.81% | 17 | 0.17% | 67 | -54.73% | 41 | -66.94% |
| Jun 30, 2025 | 321 | -3.02% | 169,479,977 | -1.03% | 100 | 0.96% | 143 | -12.80% | 123 | 18.27% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.72M | 4.48% | -5.75K |
| Vanguard Total Stock Mkt Idx Inv | 4.08M | 2.38% | 18.29K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.08M | 2.38% | 18.29K |
| Vanguard US Total Market Shares ETF | 3.89M | 2.33% | 4.42K |
| State Street® SPDR® S&P® Biotech ETF | 3.91M | 2.27% | 8.96K |
| iShares Russell 2000 ETF | 3.28M | 1.90% | -58.18K |
| First Trust NYSE Arca Biotech ETF | 3.01M | 1.77% | - |
| Vanguard Small Cap Index | 2.94M | 1.72% | -2.09K |
| Vanguard Small Cap Growth Index Inv | 1.70M | 0.99% | 47.42K |
| Vanguard Morn Small Cap Growth Index Inv | 1.70M | 0.99% | 47.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 05, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $169.64K |
| Aug 06, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $272.60K |
| Aug 06, 2026 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $145.00K |
| Jul 30, 2026 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Sell | $1.31K |
| Jul 30, 2026 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Sell | $431.35K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 5 |
| 2026 Q2 | - | 6 |
| 2026 Q1 | - | 10 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 3 |
ACAD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools